2976-8713

RSC Pharmaceutics

The Royal Society of Chemistry

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 67 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact67 DOIs
2

Deposit reference lists for 64 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact64 DOIs
3

Add abstracts to 54 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact54 DOIs

DOIs for this ISSN

Showing the top 5 of 319 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Enhancement of drug permeation across skin through stratum c… (10.1039/d4pm00089g)
ORCID
30.10 15
2 Emerging smart microneedle technologies in psoriasis: conver… (10.1039/d5pm00173k)
ORCID
26.03 10
3 Correction: Pharmaceutical salts of azole anti-fungal drugs:… (10.1039/d4pm90015d)
References
7.53 1
4 <i>In vitro</i> anti-trypanosomal activi… (10.1039/d3pm00002h)
0.00 2
5 Advances of cassava starch-based composites in novel and con… (10.1039/d3pm00008g)
0.00 32
6 Dextrin conjugation to colistin inhibits its toxicity, cellu… (10.1039/d3pm00014a)
0.00 4
7 Evaluation of the anti-depressant potential of EGCG-loaded n… (10.1039/d3pm00022b)
0.00 7
8 Nanotechnology-driven wound healing potential of asiaticosid… (10.1039/d3pm00024a)
0.00 46
9 Electrostatically hindered diffusion for predictable release… (10.1039/d3pm00025g)
0.00 2
10 A comprehensive investigation of the biophysical approach fo… (10.1039/d3pm00027c)
0.00 10
11 Molecular structure of ketoprofen-polyvinylpyrrolidone solid… (10.1039/d3pm00038a)
0.00 4
12 Comparative study on the effects of the inclusion complexes… (10.1039/d3pm00039g)
0.00 14
13 A zuranolone nanocrystal formulation enables solubility-inde… (10.1039/d3pm00043e)
0.00 4
14 Indocyanine green within glycosylated polymeric micelles as… (10.1039/d3pm00053b)
0.00 10
15 Synthesis and biological evaluation of novel hybrid compound… (10.1039/d3pm00054k)
0.00 10
16 Synthetic mucus barrier arrays as a nanoparticle formulation… (10.1039/d3pm00057e)
0.00 10
17 Elucidation of processing parameters for the reverse enginee… (10.1039/d3pm00058c)
0.00 3
18 Insight into the liposomal encapsulation of mono and bis-nap… (10.1039/d3pm00060e)
0.00 1
19 Novel alginate nanoparticles for the simultaneous delivery o… (10.1039/d3pm00068k)
0.00 30
20 Novel pH-sensitive gum ghatti- <i>cl</i>… (10.1039/d3pm00072a)
0.00 16
21 Exploring co-crystallisation as a technique for taste-maskin… (10.1039/d3pm00074e)
0.00 12
22 Polymer–drug conjugates as nano-sized multi-targeting system… (10.1039/d3pm00075c)
0.00 9
23 Green synthesis of silver nanoparticles using… (10.1039/d3pm00077j)
0.00 21
24 Development of polyethyleneimine cross-linked fucoidan nanop… (10.1039/d3pm00078h)
0.00 10
25 Cerium oxide particles: coating with charged polysaccharides… (10.1039/d3pm00081h)
0.00 11
26 Thermodynamic and spectroscopic evaluation of the eutectic m… (10.1039/d3pm00082f)
0.00 7
27 Exploring the molecular structure of lipids in the design of… (10.1039/d3pm00087g)
0.00 3
28 Biocompatible, injectable and self-healable MOF-based anti-f… (10.1039/d3pm00088e)
0.00 25
29 Pharmaceutical salts of azole anti-fungal drugs: physicochem… (10.1039/d4pm00003j)
0.00 9
30 Phenylboronic acid-derived nanovectors for gene/drug deliver… (10.1039/d4pm00005f)
0.00 10
31 Recent progress on nanosystems for nucleic acid delivery (10.1039/d4pm00009a)
0.00 14
32 Potential of ultrasonic processing in biomedical application… (10.1039/d4pm00010b)
0.00 7
33 Is receptor mediated active macrophage targeting of amphoter… (10.1039/d4pm00023d)
0.00 4
34 <i>In vitro</i> evaluation of microneedl… (10.1039/d4pm00024b)
0.00 38
35 Lysozyme activated co-delivery of latanoprost–timolol from m… (10.1039/d4pm00031e)
0.00 6
36 Antimicrobial nanoparticles: current landscape and future ch… (10.1039/d4pm00032c)
0.00 273
37 Immune-theranostic gold nanorod-based NIR-responsive nanomed… (10.1039/d4pm00033a)
0.00 7
38 Microneedle-assisted transdermal delivery of carvedilol nano… (10.1039/d4pm00038b)
0.00 12
39 Thermodynamic and kinetic analysis of the melting process of… (10.1039/d4pm00039k)
0.00 8
40 Fabrication of miconazole nitrate solid lipid nanoparticle l… (10.1039/d4pm00042k)
0.00 8
41 Doxorubicin-Polysorbate 80 conjugates: targeting effective a… (10.1039/d4pm00053f)
0.00 8
42 Comparison of emulsion and spray methods for fabrication of… (10.1039/d4pm00054d)
0.00 2
43 Insight into central nervous system targeted nanostructured… (10.1039/d4pm00057a)
0.00 13
44 Development of a naproxen and gaultheria oil based topical n… (10.1039/d4pm00059e)
0.00 9
45 Acid- and base-resistant antimicrobial hydrogels based on po… (10.1039/d4pm00062e)
0.00 4
46 A model binary system for the evaluation of novel ion pair f… (10.1039/d4pm00063c)
0.00 0
47 Structure–activity relationships of DNA nanocarriers based o… (10.1039/d4pm00065j)
0.00 5
48 Target-selective cytosolic delivery of cargo proteins using… (10.1039/d4pm00069b)
0.00 1
49 Effect of amorphous chrysin loading in hydrophobically modif… (10.1039/d4pm00074a)
0.00 7
50 Functionalized SBA-15: engineering, detailed study on releas… (10.1039/d4pm00078a)
0.00 4